| 1 |
33509441 | A pilot clinical trial of oral tetrahydrouridine/decitabine for noncytotoxic epigenetic therapy of chemoresistant lymphoid malignancies. | 2021 Jan |
1 |
| 2 |
33904891 | Cedazuridine/decitabine: from preclinical to clinical development in myeloid malignancies. | 2021 Apr 27 |
1 |
| 3 |
32860582 | Decitabine/Cedazuridine: First Approval. | 2020 Sep |
2 |
| 4 |
33042633 | A pilot clinical trial of the cytidine deaminase inhibitor tetrahydrouridine combined with decitabine to target DNMT1 in advanced, chemorefractory pancreatic cancer. | 2020 |
3 |
| 5 |
30926081 | An oral fixed-dose combination of decitabine and cedazuridine in myelodysplastic syndromes: a multicentre, open-label, dose-escalation, phase 1 study. | 2019 Apr |
2 |
| 6 |
31370878 | Novel prodrugs of decitabine with greater metabolic stability and less toxicity. | 2019 Aug 1 |
2 |
| 7 |
27646854 | Efficacy and epigenetic interactions of novel DNA hypomethylating agent guadecitabine (SGI-110) in preclinical models of hepatocellular carcinoma. | 2016 Oct 2 |
3 |
| 8 |
26296954 | Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study. | 2015 Sep |
1 |
| 9 |
23287564 | Increased CDA expression/activity in males contributes to decreased cytidine analog half-life and likely contributes to worse outcomes with 5-azacytidine or decitabine therapy. | 2013 Feb 15 |
4 |
| 10 |
23479503 | Myeloprotection by cytidine deaminase gene transfer in antileukemic therapy. | 2013 Mar |
1 |
| 11 |
21598398 | Delineation of the molecular mechanisms of nucleoside recognition by cytidine deaminase through virtual screening. | 2011 Aug 1 |
1 |
| 12 |
18221921 | Simultaneous determination of decitabine and vorinostat (Suberoylanalide hydroxamic acid, SAHA) by liquid chromatography tandem mass spectrometry for clinical studies. | 2008 Feb 15 |
1 |
| 13 |
16333246 | The human equilibrative nucleoside transporter 1 mediates in vitro cytarabine sensitivity in childhood acute myeloid leukaemia. | 2005 Dec 12 |
2 |
| 14 |
11137229 | Unnatural enantiomers of 5-azacytidine analogues: syntheses and enzymatic properties. | 2000 Nov |
1 |
| 15 |
9771951 | Drug resistance to 5-aza-2'-deoxycytidine, 2',2'-difluorodeoxycytidine, and cytosine arabinoside conferred by retroviral-mediated transfer of human cytidine deaminase cDNA into murine cells. | 1998 |
1 |
| 16 |
1375134 | Potent inhibitors for the deamination of cytosine arabinoside and 5-aza-2'-deoxycytidine by human cytidine deaminase. | 1992 |
1 |
| 17 |
1700230 | Induction of cytidine deaminase in HL-60 myeloid leukemic cells by 5-aza-2'-deoxycytidine. | 1990 |
2 |
| 18 |
6189497 | Kinetics of deamination of 5-aza-2'-deoxycytidine and cytosine arabinoside by human liver cytidine deaminase and its inhibition by 3-deazauridine, thymidine or uracil arabinoside. | 1983 Apr 1 |
1 |